XCL1 and experimental autoimmune encephalomyelitis: Recently, Matsumoto et al. [15] showed that XCL1- and ITGA9-neutralizing antibodies abrogated disease progression in experimental autoimmune encephalomyelitis and suggested XCL1/ITGA9 axis as an important signaling pair for homeostatic functions.